Showing results (2291-2300 of 9,650) with videos related to
Sort By:
Pageof 965
Leukemia|April 29, 1998
The low cycling status of mobilized peripheral blood CD34+ cells is not restricted to the more primitive subfractionA J Croockewit, R A Raymakers, M E Smeets, et al.Leukemia|April 7, 1998
Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopeniaK Shinjo, A Takeshita, S Nakamura, et al.Leukemia|April 7, 1998
FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substratesC Lavagna-Sévenier, S Marchetto, D Birnbaum, et al.Leukemia|April 28, 2015
Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapyK Fujii, M B Karpova, K Asagoe, et al.Leukemia|August 21, 2025
Unraveling the molecular landscape of Erdheim-Chester disease: new insights from methylome and transcriptome integrationMiriam Cerván-Martín, Francesco Pegoraro, Javier Martínez-López, et al.Leukemia|March 11, 2023
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP studyKate Manos, Geoffrey Chong, Colm Keane, et al.Leukemia|March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectivesGiovanni Barosi, Vittorio Rosti, Robert Peter GaleLeukemia|March 17, 2023
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse modelElisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, et al.Leukemia|March 17, 2023
Therapy-related MDS dissected based on primary disease and treatment-a nationwide perspectiveDaniel Moreno Berggren, Hege Garelius, Petter Willner Hjelm, et al.Pageof 965